I. Girault

发表

Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance.

J. Mosnier, D. Laplaud, S. Conchon, 2020, The Journal of clinical investigation.

Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution

A. Poupon, J. Mosnier, R. Danger, 2021, Science Advances.

In situ detection of the eIF4F translation initiation complex in mammalian cells and tissues

S. Shen, C. Robert, S. Vagner, 2021, STAR protocols.

Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccine

G. Teppaz, T. Bourquard, D. Debieuvre, 2020 .

Neuropilin-1 cooperates with PD-1 in CD8+ T cells predicting outcomes in melanoma patients treated with anti-PD1

J. Davoust, Joel Babdor, J. Scoazec, 2022, iScience.

Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells

A. Urrutia, C. Cordier, C. Bourgeois, 2010, European journal of immunology.

Increased CD 127 expression on activated FOXP 3 + CD 4 + regulatory T cells

A. Urrutia, C. Cordier, C. Bourgeois, 2010 .

Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Speciﬁc CD8 (cid:2) T Cell Response in HIV Controllers

C. Rouzioux, L. Meyer, O. Lambotte, 2013 .

Acute Plasma Biomarkers of T Cell Activation Set-Point Levels and of Disease Progression in HIV-1 Infection

F. Barré-Sinoussi, B. Jacquelin, M. Müller-Trutwin, 2012, PloS one.

Early and long lasting alteration of Effector CD 45 RA-Foxp 3 high Regulatory T cells homeostasis during HIV infection

O. Lambotte, M. Sinet, C. Goujard, 2013 .

during HIV infection

O. Lambotte, C. Goujard, C. Lécuroux, 2012 .

Potential Role for HIV-Specific CD38−/HLA-DR+ CD8+ T Cells in Viral Suppression and Cytotoxicity in HIV Controllers

O. Lambotte, M. Sinet, A. Sáez-Cirión, 2014, PloS one.

Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy.

J. Scoazec, J. Girard, F. Lafouresse, 2022, Cancer cell.

A dose escalation phase 1 study of radiotherapy (RT) in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody ipilimumab (Ipi) in patients (pts) with metastatic melanoma

A. Eggermont, N. Chaput, J. Adam, 2016 .

Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell lines

C. Robert, L. Désaubry, S. Vagner, 2016, Cell cycle.

Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma

N. Sonenberg, A. Eggermont, J. Adam, 2018, Nature Medicine.

A PD-1/PD-L1 Proximity Assay as a Theranostic Marker for PD-1 Blockade in Patients with Metastatic Melanoma

J. Adam, S. Warren, S. Shen, 2021, Clinical Cancer Research.

CLEC-1 is a death sensor that limits antigen cross-presentation by dendritic cells and represents a target for cancer immunotherapy

J. Poschmann, E. Chiffoleau, C. Fourgeux, 2022, Science advances.

Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF-CRAF Heterodimerization.

A. Eggermont, J. Adam, C. Robert, 2016, Cancer research.

CD8 T-Cells from Most HIV-Infected Patients Lack Ex Vivo HIV-Suppressive Capacity during Acute and Early Infection

C. Rouzioux, L. Meyer, A. Sáez-Cirión, 2013, PloS one.

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

Brigitte Autran, Laurence Meyer, Asier Sáez-Cirión, 2013, PLoS pathogens.

Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Specific CD8+ T Cell Response in HIV Controllers

C. Rouzioux, L. Meyer, O. Lambotte, 2013, Journal of Virology.

eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies

A. Eggermont, C. Robert, N. Ribeiro, 2014, Nature.

Identification of a particular HIV-specific CD8+ T-cell subset with a CD27+ CD45RO-/RA+ phenotype and memory characteristics after initiation of HAART during acute primary HIV infection.

L. Meyer, M. Sinet, A. Urrutia, 2009, Blood.

Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy.

F. André, P. Dessen, V. Lazar, 2013, Cancer research.

Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma

A. Eggermont, C. Robert, J. Scoazec, 2019, Cancer Immunology, Immunotherapy.

NKG2D Expression on HIV-Specific CD8+ T cells Is Reduced in Viremic HIV-1–Infected Patients but Maintained in HIV Controllers

D. Scott‐Algara, O. Lambotte, A. Sáez-Cirión, 2013, Journal of acquired immune deficiency syndromes.

Hiv-1 Control after Transient Antiretroviral Treatment Initiated in Primary Infection: Role of Patient Characteristics and Effect of Therapy

C. Rouzioux, L. Meyer, M. Sinet, 2012, Antiviral therapy.

Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells

B. Autran, L. Meyer, O. Lambotte, 2009, AIDS.

Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance

I. Girault, A. Patiño-García, F. Lecanda, 2013, Cell Death and Disease.

Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection.

O. Lambotte, M. Sinet, C. Goujard, 2012, The Journal of infectious diseases.

ChemR23 activation reprograms macrophages toward a less inflammatory phenotype and dampens carcinoma progression

S. Barillé-Nion, J. Fresquet, P. Juin, 2023, Frontiers in immunology.

A dose escalation phase 1 study of radiotherapy (RT) in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody ipilimumab in patients (pts) with metastatic melanoma.

A. Eggermont, N. Chaput, J. Adam, 2017 .

Biomarker study evaluating the combination of dabrafenib (D) with trametinib (T) versus the combination after 8 weeks of monotherapy with dabrafenib or trametinib in patients with metastatic and unresectable stage IIIC or IV melanoma: GSK study 116613.

C. Robert, M. Thomas, S. Vagner, 2014 .

Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells

A. Urrutia, C. Cordier, C. Bourgeois, 2010, European journal of immunology.

Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma

N. Sonenberg, A. Eggermont, J. Adam, 2018, Nature Medicine.

Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection.

M. Sinet, C. Lécuroux, C. Bourgeois, 2012, The Journal of infectious diseases.